Table 5.
N | % | |
---|---|---|
Prophylactic prescription of antibiotics for cardiac conditions (correct answers)* | ||
Prosthetic cardiac valves (n=140) | 135 | 96.4 |
Rheumatic heart disease (n=131) | 26 | 19.8 |
Mitral valve prolapsed with valvular regurgitation (n=124) | 16 | 12.9 |
Previous infective endocarditis (n=127) | 102 | 80.3 |
Previous coronary artery bypass graft surgery (n=140) | 70 | 50.0 |
Hypertrophic cardiomyopathy (n=147) | 84 | 26.1 |
Intravascular cardiac pacemakers (n=147) | 49 | 33.3 |
Myocardial infarct in the last 6 months (n=125) | 26 | 20.8 |
Cardiac transplantation recipients who develop cardiac valvulopathy (n=131) | 65 | 49.6 |
Unrepaired cyanotic heart disease (n=134) | 57 | 42.5 |
Recently placed coronary stents (n=144) | 30 | 20.8 |
Atrial septal defect after 6 months of repair (n=134) | 59 | 44.0 |
Ventricular septal defect with repair (n=140) | 56 | 40.0 |
Patent ductus arteriosus (n=140) | 56 | 40.0 |
Cardiac catheterization without stents (less than 1 year) (n=183) | 61 | 43.9 |
Prophylactic prescription of antibiotics for other conditions (in case of invasive procedure) (correct answers)* | ||
Human immunodeficiency virus (n=155) | 90 | 58.1 |
Neutropenia (n=132) | 51 | 38.6 |
Cancer chemotherapy (n=136) | 81 | 59.6 |
Diabetes (n=245) | 188 | 76.7 |
Hematopoietic stem cell or solid organ transplantation (n=133) | 56 | 42.1 |
Bisphosphonate therapy (n=173) | 62 | 35.8 |
Chronic steroid usage (n=172) | 91 | 52.9 |
Asplenism or status post splenectomy (n=175) | 69 | 39.4 |
Patients with prosthetic joints (n=173) | 16 | 9.2 |
Valid percentages are reported